E-TACE
Sponsors
Xuhua Duan
Conditions
CarcinomaHepatocellular Carcinoma
Unknown Phase
A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)
NCT06023147
Start: 2023-09-10End: 2025-09-10Target: 298Updated: 2023-09-07
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
Not yet recruitingNCT07180459
Start: 2025-10-10End: 2027-10-10Target: 118Updated: 2025-09-18